<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-33983" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>111 Indium White Blood Cell Scan</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Herron</surname>
            <given-names>Tom</given-names>
          </name>
          <aff>University Hospitals Cleveland Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gossman</surname>
            <given-names>William</given-names>
          </name>
          <aff>Creighton University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tom Herron declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>William Gossman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-33983.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The indium 111-tagged white blood cell (WBC) scan is a type of imaging modality used to help identify regions of inflammation and, thus, infections when other imaging studies are equivocal or contraindicated.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref>&#x000a0;Clinicians commonly use this test to evaluate prosthetic joint infections, osteomyelitis, vascular graft infections, and fever of unknown origin.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref>&#x000a0;The overall accuracy in diagnosing the infections above using indium 111-tagged WBC scan has widely ranged in the literature from sensitivity 60&#x000a0;to 100% and specificity 69&#x000a0;to 92%.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref>&#x000a0;Briefly, white blood cells (WBCs) are obtained from a blood sample from a patient, tagged with the radioisotope indium-111, and then re-injected intravenously into the patient. These labeled leukocytes localize to a region of inflammation visible on the whole body or through regional nuclear imaging with bone scintigraphy.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref><xref ref-type="bibr" rid="article-33983.r2">[2]</xref></p>
      </sec>
      <sec id="article-33983.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>The patient&#x02019;s blood is drawn in a vial and placed in a centrifuge. This process separates the plasma from red blood cells. It is essential to ensure that an anticoagulant such as heparin or acid citrate dextrose is used in the collection tube to prevent blood clotting.<xref ref-type="bibr" rid="article-33983.r2">[2]</xref>&#x000a0;The plasma is again centrifuged to separate the platelet-rich plasma from the sample. The leukocytes are then obtained and suspended in a saline solution, and the application of the radiopharmaceutical 111-indium solution to the patient&#x02019;s sample follows.<xref ref-type="bibr" rid="article-33983.r2">[2]</xref>&#x000a0;This solution is then re-injected into the patient. It is important to ensure appropriate personal protective safety equipment, aseptic technique, proper patient labeling, and the use of controls throughout the specimen collection process.<xref ref-type="bibr" rid="article-33983.r2">[2]</xref><xref ref-type="bibr" rid="article-33983.r3">[3]</xref></p>
      </sec>
      <sec id="article-33983.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>After the indium-labeled white blood cells are injected into the patient, the patient undergoes nuclear imaging. The patient must be able to cooperate for roughly 60 minutes to obtain the imaging scans.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;No special preparation is required for the test. Approximately 1&#x000a0;to 2 hours after the sample is radiolabeled with the indium-111, it is re-injected into the patient.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;Labeled WBCs stored greater than 3 hours before administration have decreased viability.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;The administered recommended dose for adults is 0.3&#x000a0;to 0.5 mCi.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;Further information regarding radiation dosing can be found in the "complications" section below. Depending on the clinical situation, imaging is obtained at varying intervals after administering the tagged white blood cells. It is most common to obtain imaging 1&#x000a0;to 4 hours after administration or 16&#x000a0;to 30 hours after, depending on the clinical situation.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref></p>
      </sec>
      <sec id="article-33983.s4" sec-type="Indications">
        <title>Indications</title>
        <p>111-Indium white blood cell scan may be utilized to detect and localize the site of infection and to correlate clinically with the patient presentation of various pathologic processes, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Osteomyelitis not involving the spine (radionucleotide scans utilizing gallium are superior to indium alone in detecting osteomyelitis of the spine).<xref ref-type="bibr" rid="article-33983.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Prosthetic joint infection&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Vascular grafts</p>
          </list-item>
          <list-item>
            <p>Intra-abdominal infections</p>
          </list-item>
          <list-item>
            <p>Abscesses</p>
          </list-item>
          <list-item>
            <p>Endocarditis</p>
          </list-item>
          <list-item>
            <p>Foot ulcers</p>
          </list-item>
          <list-item>
            <p>Infected implanted devices such as central venous catheters</p>
          </list-item>
          <list-item>
            <p>Fevers of unknown origin when there is a high probability of infection</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease&#x000a0;<xref ref-type="bibr" rid="article-33983.r2">[2]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-33983.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>All of the indications mentioned above are potential diagnoses that are potentially obtainable from using a 111-indium white blood cell scan.<xref ref-type="bibr" rid="article-33983.r2">[2]</xref>&#x000a0;111-indium-tagged white blood cell scans also require cooperation and effective communication between the entire multidisciplinary team to maximize patient outcomes.<xref ref-type="bibr" rid="article-33983.r5">[5]</xref>&#x000a0;Radionulcleotide scans alone are typically insufficient as a solitary test but are best interpreted and used with the patient&#x02019;s specific presentation.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref></p>
      </sec>
      <sec id="article-33983.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>Interpretation of a radionucleotide-labeled leukocyte study requires knowledge of normal and abnormal variants. Normal findings at 18&#x000a0;to 24 hours of the study include uptake primarily by the spleen, liver, and bone marrow reticuloendothelial system.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;Diffuse pulmonary activity occurs up to 4 hours after injection, which is a normal finding.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;When detecting an abscess, the uptake in that pathologic area may have uptake either greater than or equal to the uptake of the liver. Up to one-half of the cases can be visualized&#x000a0;4 hours after injection, with greater than 90% uptake by 24 hours.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref></p>
        <p>In cases of osteomyelitis, radiolabeled indium-111 uptake significantly increases. However, suppose a patient has been receiving treatment with IV antibiotics before obtaining a nuclear scan with radiolabeled indium. In that case, the results may show limited uptake in that area, producing a false negative result.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;In cases of infected orthopedic hardware, the indium 111-tagged leukocyte scan shows uptake that usually increases in the area of interest. However, orthopedic hardware or a prosthesis may make radiological interpretation difficult as the orthopedic device displaces bone marrow.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;In this case, it may be necessary to compare and localize the area of interest with a 99mTc-sulfur SPECT, as acute infection may have high uptake on the 111-indium WBC scan with discordant activity on a 99m-Tc-sulfur study.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref></p>
      </sec>
      <sec id="article-33983.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>There are potential false positives and negatives when interpreting a 111-indium leukocyte scan.&#x000a0;There is the possibility for localization of uptake in instances unrelated to infection.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref>&#x000a0;These include an accessory spleen, acute bleed/hematomas, neoplasms, foreign body inflammatory response, and inflammatory bowel disease.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;Noninfectious etiologies of increased uptake on 111-indium nuclear scans include rheumatoid and gouty arthritis, which may also lead to false-positive interpretations.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;When concerned with infectious etiologies of the gastrointestinal tract, it is important to note that the labeled 111-indium WBC scan does not accumulate in normal bowel.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;This contrasts with the 99mTc labeled scan, thus potentially producing a false positive result during the interpretation of the indium 111-tagged leukocyte nuclear scan.<xref ref-type="bibr" rid="article-33983.r6">[6]</xref></p>
        <p>Pathological disease processes, including chronic abscess, any lymphocytic mediated infection such as sarcoidosis or tuberculosis, and hepatic or splenic abscess given these organs uptake 111 indium to metabolize may cause false-negative nuclear scans with 111- indium.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0; Given the numerous false positive and false negative interpretations of the 111-indium WBC labeled nuclear scan, correlating clinically to a specific patient's history and physical exam, as well as previously obtained imaging studies, is extremely important.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref><xref ref-type="bibr" rid="article-33983.r3">[3]</xref></p>
      </sec>
      <sec id="article-33983.s8" sec-type="Complications">
        <title>Complications</title>
        <p>A 111-indium white blood cell scan complication is radiation exposure, mostly affecting the organs that metabolize the indium, such as the spleen, liver, and bone marrow.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref>&#x000a0;The average effective radiation dose for nuclear medicine procedures ranges from 0.3 to 20 mSv.<xref ref-type="bibr" rid="article-33983.r7">[7]</xref>&#x000a0;The recommended dose per year is no greater than 50 mSv.<xref ref-type="bibr" rid="article-33983.r7">[7]</xref>&#x000a0;On average, a tagged WBC scan with indium is nearly equivalent to a chest CT scan.<xref ref-type="bibr" rid="article-33983.r7">[7]</xref>&#x000a0;Adults are recommended to dose 0.3&#x000a0;to .5 mCi. The recommended radiation dose for pediatric patients is weight-based at 0.004&#x000a0;to 0.007 mCi/kg. Therefore, the clinical utility of obtaining a 111-indium labeled white blood cell scan should be indicated, and the clinician should discuss it with the patient.<xref ref-type="bibr" rid="article-33983.r3">[3]</xref></p>
      </sec>
      <sec id="article-33983.s9" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>Before obtaining a radiolabeled nuclear scan with indium, discussing the clinical utility, radiation exposure, and overall process of a 111-indium WBC scan with patients is essential.&#x000a0;</p>
      </sec>
      <sec id="article-33983.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The indium 111-tagged white blood cell scan is used to help identify regions of inflammation and, thus, infections when other imaging studies are equivocal or contraindicated.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref>&#x000a0;In addition to a 111-indium WBC scan, the gallium 67 radiolabeled scan has been used previously as a type of nuclear imaging scan.<xref ref-type="bibr" rid="article-33983.r8">[8]</xref>&#x000a0;However, gallium 67 scans may require up to 72 hours of waiting from the time of injection to the time of nuclear imaging, further delaying potential treatment of suspected infection.<xref ref-type="bibr" rid="article-33983.r8">[8]</xref>&#x000a0;Compared to the Gallium 67 radionucleotide scans, 111-indium has superior specificity in osteomyelitis, fever of unknown origin, and prosthetic joint infections.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref>&#x000a0;For patients with suspected prosthetic joint infection, vascular grafts, intra-abdominal infections, abscesses, endocarditis, foot ulcers, infected implanted devices such as central venous catheters, fevers of unknown origin when there is a high probability of infection, and Inflammatory bowel disease, sensitivity, and specificity has ranged from 60&#x000a0;to 100% and 69&#x000a0;to 92%, respectively.<xref ref-type="bibr" rid="article-33983.r1">[1]</xref><xref ref-type="bibr" rid="article-33983.r9">[9]</xref><xref ref-type="bibr" rid="article-33983.r10">[10]</xref>&#x000a0;A radiolabeled&#x000a0;WBC scan with indium used in the appropriate clinical setting has well-documented clinical utility.</p>
      </sec>
      <sec id="article-33983.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=33983&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=33983">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/33983/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=33983">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-33983.s12">
        <title>References</title>
        <ref id="article-33983.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Clinical utility of indium 111-labeled white blood cell scintigraphy for evaluation of suspected infection.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>ofu089</fpage>
            <pub-id pub-id-type="pmid">25734155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Jamar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Israel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Signore</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>835</fpage>
            <page-range>835-41</page-range>
            <pub-id pub-id-type="pmid">20198474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seabold</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Forstrom</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Schauwecker</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Datz</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>McAfee</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Royal</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Procedure guideline for indium-111-leukocyte scintigraphy for suspected infection/inflammation. Society of Nuclear Medicine.</article-title>
            <source>J Nucl Med</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>997</fpage>
            <page-range>997-1001</page-range>
            <pub-id pub-id-type="pmid">9189160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Radionuclide imaging of osteomyelitis.</article-title>
            <source>Semin Nucl Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-46</page-range>
            <pub-id pub-id-type="pmid">25475377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peek</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Interdisciplinary relationship dynamics.</article-title>
            <source>Am J Health Syst Pharm</source>
            <year>2020</year>
            <month>Mar</month>
            <day>05</day>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>424</fpage>
            <page-range>424-426</page-range>
            <pub-id pub-id-type="pmid">31961385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Signore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jamar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Israel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Buscombe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martin-Comin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lazzeri</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>1816</fpage>
            <page-range>1816-1831</page-range>
            <pub-id pub-id-type="pmid">29850929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Censullo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vijayan</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Using Nuclear Medicine Imaging Wisely in Diagnosing Infectious Diseases.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2017</year>
            <season>Winter</season>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>ofx011</fpage>
            <pub-id pub-id-type="pmid">28480283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rennen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Boerman</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Corstens</surname>
                <given-names>FH</given-names>
              </name>
            </person-group>
            <article-title>Imaging infection/inflammation in the new millennium.</article-title>
            <source>Eur J Nucl Med</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>241</fpage>
            <page-range>241-52</page-range>
            <pub-id pub-id-type="pmid">11303896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spacek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Belohlavek</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Votrubova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sebesta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stadler</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2009</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>850</fpage>
            <page-range>850-8</page-range>
            <pub-id pub-id-type="pmid">19107480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-33983.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kjaer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lebech</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of (111)In-granulocyte scintigraphy in patients with fever of unknown origin.</article-title>
            <source>J Nucl Med</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-4</page-range>
            <pub-id pub-id-type="pmid">11850476</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
